Market Overview

UPDATE: Sterne Agee Downgrades Vitamin Shoppe on Slowed Traffic/NSP

Share:
Related VSI
Wall Street's M&A Chatter From March 21
Earnings Scheduled For March 1, 2017

In a report published Friday, Sterne Agee analyst Charles Grom downgraded the rating on Vitamin Shoppe (NYSE: VSI) from Buy to Neutral, and lowered the price target from $54.00 to $45.00.

In the report, Sterne Agee noted, “Once a model of consistency, something seems off with the VSI model as traffic has stalled and NSP has slowed considerably. While this isn't necessarily new news today, we don't have firm answers to many questions and with 1) a fickle consumer, 2) competitive pressures augmenting, and 3) peak EBIT, we can't identify a catalyst NT to jump-start VSI. Also, after scrubbing our model, the Street looks too high, so we adjust our EPS accordingly. Net, move to Neutral/PT to $45 from $54.”

Vitamin Shoppe closed on Thursday at $41.96.

Latest Ratings for VSI

DateFirmActionFromTo
Jan 2017Goldman SachsDowngradesNeutralSell
Jan 2017Morgan StanleyDowngradesEqual-WeightUnderweight
Nov 2016Morgan StanleyDowngradesOverweightEqual-Weight

View More Analyst Ratings for VSI
View the Latest Analyst Ratings

Posted-In: Charles Grom Sterne AgeeAnalyst Color Downgrades Analyst Ratings

 

Related Articles (VSI)

View Comments and Join the Discussion!